Inhibiting Cell Death to Preserve Vision in Retinal Diseases

Connie Chang, chief operating officer for ONL Therapeutics, discusses the role Fas-signaling plays in cell death, how this underlies a number of retinal diseases, and the company’s experimental therapy to inhibit Fas signaling to treat these conditions.